Lagociclovir valactate
Lagociclovir valactate is a prodrug of Lagociclovir (HY-14844). Lagociclovir valactate is an orally active anti-HBV agent.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1001670-19-4
- Formule: C19H27FN6O6
- Masse moléculaire:454.45
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
HBV[1]
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Woodchucks with chronic WHV infection[1]
-
Dosage:20 or 60 mg/kg
-
Administration:Oral, daily for 10 weeks
-
Result:Reduced WHV viremia effectively and maintained WHV DNA at a very low level.
-
Animal Model:Woodchucks[1]
-
Dosage:10 or 40 mg/kg
-
Administration:Oral (Pharmacokinetic Analysis)
-
Result:Average pharmacokinetic parameters for Lagociclovir after oral administration of Lagociclovir valactate to healthy and chronically WHV infected woodchucks[1]
Pharmacokinetic parameter for Lagociclovir Healthy woodchucks (n = 4) receiving Lagociclovir valactate at 10 mg/kg Healthy woodchucks (n = 4) receiving Lagociclovir valactate at 40 mg/kg WHV-infected woodchucks (n = 14) receiving Lagociclovir valactate at 60 mg/kg Cmax (μM) 0.54 ± 0.14 2.10 ± 1.5 3.50 ± 1.9 Tmax (h) 4.10 ± 1.0 3.30 ± 1.5 2.90 ± 1.1 AUC0-∞ (μM • h/liter) 5.15 ± 1.0 10.50 ± 4.2 20.1 ± 11.3 t1/2 (h) 5.44 ± 1.2 4.20 ± 1.6 4.7 ± 0.8
Chemical Information
-
CAS No. 1001670-19-4
-
Masse moléculaire 454.45
-
Formule C19H27FN6O6
-
SMILES
O=C1C2=C(NC(N)=N1)N([C@](C[C@@H]3F)(C)O[C@@H]3COC([C@H](C)OC([C@@H](N)C(C)C)=O)=O)C=N2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)